<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0B5C4660-E127-4BC5-A05F-FFEE95EED6F1"><gtr:id>0B5C4660-E127-4BC5-A05F-FFEE95EED6F1</gtr:id><gtr:name>The interNational Early Onset Paediatric IBD Cohort Study (NEOPICS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/487043E2-21FC-4052-A0CA-AB404DE87BA4"><gtr:id>487043E2-21FC-4052-A0CA-AB404DE87BA4</gtr:id><gtr:name>Children's Hospital of Philadelphia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AABC0E98-CD3E-4417-9B0A-536F2E1F1D91"><gtr:id>AABC0E98-CD3E-4417-9B0A-536F2E1F1D91</gtr:id><gtr:name>Royal College of Paediatrics and Child Health (RCPCH)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1E3015FF-23BB-4B73-8C80-84C53F33B745"><gtr:id>1E3015FF-23BB-4B73-8C80-84C53F33B745</gtr:id><gtr:name>Hospital for Sick Children, Toronto</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E55B119-02E7-43F3-9B39-DD48A6511372"><gtr:id>4E55B119-02E7-43F3-9B39-DD48A6511372</gtr:id><gtr:name>Addenbrooke's Hospital</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>School of Clinical Sciences</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0B5C4660-E127-4BC5-A05F-FFEE95EED6F1"><gtr:id>0B5C4660-E127-4BC5-A05F-FFEE95EED6F1</gtr:id><gtr:name>The interNational Early Onset Paediatric IBD Cohort Study (NEOPICS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/487043E2-21FC-4052-A0CA-AB404DE87BA4"><gtr:id>487043E2-21FC-4052-A0CA-AB404DE87BA4</gtr:id><gtr:name>Children's Hospital of Philadelphia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AABC0E98-CD3E-4417-9B0A-536F2E1F1D91"><gtr:id>AABC0E98-CD3E-4417-9B0A-536F2E1F1D91</gtr:id><gtr:name>Royal College of Paediatrics and Child Health (RCPCH)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1E3015FF-23BB-4B73-8C80-84C53F33B745"><gtr:id>1E3015FF-23BB-4B73-8C80-84C53F33B745</gtr:id><gtr:name>Hospital for Sick Children, Toronto</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E55B119-02E7-43F3-9B39-DD48A6511372"><gtr:id>4E55B119-02E7-43F3-9B39-DD48A6511372</gtr:id><gtr:name>Addenbrooke's Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2D2B4DD8-6504-4ACE-B241-8F52943A09A8"><gtr:id>2D2B4DD8-6504-4ACE-B241-8F52943A09A8</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Russell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/89BA485B-7769-4A31-9B5A-33FC964268AB"><gtr:id>89BA485B-7769-4A31-9B5A-33FC964268AB</gtr:id><gtr:firstName>Jack</gtr:firstName><gtr:surname>Satsangi</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B4B0DFFB-30A0-48DC-B184-32C008977402"><gtr:id>B4B0DFFB-30A0-48DC-B184-32C008977402</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Wilson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800675"><gtr:id>EEB85435-9BFD-433E-B385-6C33CDF51279</gtr:id><gtr:title>The Paediatric-Onset Inflammatory Bowel Disease Cohort and Treatment Study (PICTS)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800675</gtr:grantReference><gtr:abstractText>Inflammatory bowel disease (IBD) is a common problem in children and teenagers, with significant embarrassing symptoms, effects on growth and development, and interference with school progress, family and social life. There have been few successful research trials of therapies in childhood IBD, so we draw conclusions from studies in adults with IBD, where the issues can be different. Throughout Scotland, many children and teenagers (more than 450) have already joined our research study into the causes (in terms of genetic makeup and triggers in the environment) of IBD. This group is called a cohort, and our studies have been very successful in scientific terms to date. Although we have studied all potentially important genes that may have a role in the cause of IBD, none have been shown to have a major role ? the responsible genetic causes have yet to be found! 

We are increasing the numbers of Scottish children and young people in the cohort, which will help identify more potential genetic and environmental causes. We also wish to perform trials of therapies which will answer key questions such as what is the best treatment?, what side effects can occur? With a larger group, we can also show the expected course of some of the rarer forms of childhood IBD, such as oral Crohn?s disease, perianal-only Crohn?s disease, and ulcerative colitis of only the rectum, which have been poorly studied in childhood to date.</gtr:abstractText><gtr:technicalSummary>This project will focus on the consolidation and expansion of a proven, scientifically important cohort of Scottish patients with childhood-onset inflammatory bowel disease (IBD). Scottish families with IBD strongly support this research, with over 450 cases in the cohort to date, all with comprehensive phenotypic description and extensive genetic analysis. Expansion will allow a near-complete ascertainment of cases of IBD diagnosed 16 years of age in Scotland, provide a complete geographical spread throughout Scotland, and expand numbers in the rarer subtypes of IBD. Follow-up will allow characterisation of disease progression, natural history, responsiveness to therapy, and of pathogenetic factors.

SUCCESS OF COHORT TO DATE:
? Enrollment of over 450 cases of childhood-onset IBD in Scotland
? Built on epidemiological study of this population for more than 4 decades and genetic studies for the last 8 years
? Very high acceptance by children and families ( 99% recruitment in SE Scotland)
? Rigorous and extensive phenotypic characterisation of cohort
? Demonstration of extensive disease at childhood diagnosis and rapid progression in extent and disease behaviour
? Demonstration of geographical and socio-economic variance in disease prevalence within Scotland
? High impact publications on paediatric phenotype and genotype-phenotype relationships
? Research group at international forefront of phenotypic and genotypic analysis of childhood-onset IBD
? Close links with international groups with similar childhood-onset IBD cohorts, and also more widely in adult Gastroenterology
? Development of paediatric clinician scientists with skills in translation medicine
? 500,000 SNP genetic profiling of 410 Scottish children with IBD available shortly

EXPECTED RESULTS OF EXPANSION OF THIS COHORT:
? Increase in cohort size to 1000 by 3 year study end
? Completion of full geographical ascertainment will permit further study of epidemiological and environmental risk factors for IBD
? Characterisation of pathogenetic factors by parallel epidemiological, genetic, serological, and proteomic studies
? Fuller characterisation of disease progression and natural history, especially in rarer sub-types of IBD
? Intervention studies ? pilot feasibility RCT and full RCT for both induction of remission and maintenance of remission in childhood-onset IBD
? Characterisation of responsiveness to therapy
? Determination of safety of exposure to new biological therapies in IBD</gtr:technicalSummary><gtr:fund><gtr:end>2014-03-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>815162</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Pharmacogenetics Unit Liverpool</gtr:department><gtr:description>ABCB5 function in corticosteroid response in inflammatory bowel disease</gtr:description><gtr:id>F38041A8-7FB0-49BA-92B0-D9D391F2E4A6</gtr:id><gtr:impact>ABCB5-MEDIATED TRANSPORT OF CORTICOSTEROIDS: A ROLE FOR ABCB5 IN INFLAMMATORY BOWEL DISEASE
Oral abstract presented at the United European Gastroenterology Week 2011. Manuscript preparation in progress.</gtr:impact><gtr:outcomeId>jHmT8cEJN4j-1</gtr:outcomeId><gtr:partnerContribution>Co-application of a successful project grant from National Association of Crohn's and Colitis to study the functional effect of ABCB5 on steroid response - further expanding our unit's expertise in translating genetic to functional work.</gtr:partnerContribution><gtr:piContribution>We made the discovery of 4 genes that predicted the outcomes of corticosteroid response using our patient cohort and have collaborated with the national pharmacogenetics unit to further investigate the functional consequence of the top ranking gene, ABCB5 gene. This work is still in progress but has so far revealed new insight that this gene participates in basolateral transport of corticosteroids in the intestinal epithelium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The interNational Early Onset Paediatric IBD Cohort Study (NEOPICS)</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>NEOPICS</gtr:description><gtr:id>62101066-DD24-4C4E-AE6E-5603A4987393</gtr:id><gtr:impact>Multidisciplinary - laboratory, translational and clinical colleagues.

Publication - HH Uhlig, T Schwerd, S Koletzko, N Shah, J Kammermeier, A Elkadri, J Ouahed, DC Wilson, S Travis, D Turner, C Klein, SB Snapper, AM Muise. Very early onset inflammatory bowel disease - diagnostic approach to complex monogenic diseases. Gastroenterology 2014 (in press).

Meeting - participation by Prof DC Wilson at 'VEOIBD 2014' meeting, Toronto, 16/10/14</gtr:impact><gtr:outcomeId>5464c65e28c398.89430129-1</gtr:outcomeId><gtr:partnerContribution>Ongoing genomic, pathway and functional analysis of VEOIBD p[atients.</gtr:partnerContribution><gtr:piContribution>Provision of clinical, phenotypic data and DNA on very-early onset IBD patients (VEOIBD; &amp;lt;10 years old at diagnosis)</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Children's Hospital of Philadelphia</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>International Paediatric Inflammatory Bowel Disease Genetics Consortium</gtr:description><gtr:id>B3E8FAC1-B775-4A85-BE56-76B0F22ED47B</gtr:id><gtr:impact>3 publications to date:

K Wang, H Zhang, S Kugathasan, V Annese, JP Bradfield, RK Russell, PMA Sleiman, M Imielinski, J Glessner, C Hou, DC Wilson, T Walters, C Kim, EC. Frackelton, P Lionetti, A Barabino, J Van Limbergen, S Guthery, L Denson, D Piccoli, M Li, M Dubinsky, M Silverberg, A Griffiths, SFA Grant, J Satsangi, R Baldassano, H Hakonarson. Diverse Genome-wide Association Studies Associate the IL12/IL23 Pathway with Crohn Disease. American Journal of Human Genetics 2009; 84: 399-405

M Imielinski, RN Baldassano, A Griffiths, RK Russell, V Annese, M Dubinsky, S Kugathasan, J Bradfield, T Walters, P Sleiman, C Kim, A Muise, K Wang, J Glessner, S Saeed, H Zhang, E Frackelton, C Hou, J Flory, G Otieno, R Chiavacci, R Grundmeier, M Castro, A Latiano, B Dallapiccola, J Stempak, DJ Abrams, K Taylor, D McGovern, Western Regional Research Alliance for Pediatric IBD, International IBD Genetics Consortium, MB Heyman, GD Ferry, B Kirschner, J Lee, J Essers, R Grand, M Stephens, A Levine, D Piccoli, J Van Limbergen, S Cucchiara, DS Monos, SL Guthery, L Denson, DC Wilson, SFA Grant, M Daly, M Silverberg, J Satsangi, H Hakonarson. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nature Genetics 2009; 41: 1335-40.

K Wang, R Baldassano, H Zhang, H-Q Qu, M Imielinski1, S Kugathasan, V Annese, M Dubinsky, JI Rotter, RK Russell, JP Bradfield, PMA Sleiman, JT Glessner, T Walters, C Hou, C Kim, EC Frackelton, M Garris, J Doran, C Romano, C Catassi, J Van Limbergen, S Guthery, L Denson, D Piccoli, M Silverberg,
 CA Stanley, D Monos, DC Wilson, A Griffiths, SFA Grant, J Satsangi, C Polychronakos, H Hakonarson. Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. Human Molecular Genetics 2010; 19 (10): 2059-2067.</gtr:impact><gtr:outcomeId>60937546399-1</gtr:outcomeId><gtr:partnerContribution>Genetic analysis by GWAS, pathway analysis in IBD, intellectual input</gtr:partnerContribution><gtr:piContribution>Data sharing, intellectual input</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hospital for Sick Children, Toronto</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>Edinburgh-Toronto paediatric IBD collaboration</gtr:description><gtr:id>2682344A-D103-4598-9216-12CE5EB62DEC</gtr:id><gtr:impact>AM Muise, T Walters, G Shen-Tu, G Lam, J Bennitz, J van Limbergen, C Hui, B-Y Ngan, W Xu, PM Sherman, RH Duerr, J Cho, J Satsangi, DC Wilson, AM Griffiths, M Glogauer, MS Silverberg, JH Brumell. Single nucleotide polymorphisms that increase expression of the guanosine triphosphatase RAC1 are associated with ulcerative colitis. Gastroenterology 2011; 141; 633-41.

AM Muise, W Xu, C-H Guo, T Walters, VM Wolters, R Fattouh, G Lam, P Hu , R Murchie, M Sherlock, JC Gana, RK Russell, M Glogauer, RH Duerr, J Cho, CW Lees, J Satsangi, DC Wilson, AD Paterson, AM Griffiths, MS Silverberg, JH Brumell. NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2. Gut 2011 (Epub ahead of print)</gtr:impact><gtr:outcomeId>1B6DA890A35-1</gtr:outcomeId><gtr:partnerContribution>Analysis of genes and proteins involved in susceptibility to Inflammatory Bowel Disease</gtr:partnerContribution><gtr:piContribution>Access to data, intellectual input</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UK IBD Genetics Consortium</gtr:description><gtr:id>187FD31B-E451-41ED-8FA6-5106CAD20FBB</gtr:id><gtr:impact>Contribution of 650 samples to international immunochip experiment. Analysis underway, 1st abstract published, 1st manuscript submitted 11/2011 to Nature Genetics.</gtr:impact><gtr:outcomeId>CstJ49aCqDn-1</gtr:outcomeId><gtr:partnerContribution>Joining our paediatric IBD research to the larger, established UK adult IBD genetics work.</gtr:partnerContribution><gtr:piContribution>I am paediatric lead for UK in this collaboration, given that I am lead of UK and Irish paediatric IBD genetics group, a new constituent part of this consortium, and have attracted external funding as PI to form the paediatric group.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Addenbrooke's Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>International IBD genetics consortium</gtr:description><gtr:id>DCD5F6AC-8BB5-4DCC-911C-3AE66E97023F</gtr:id><gtr:impact>2 publications, further published abstracts:

A Franke, , DPB McGovern, JC Barrett, K Wang, GL Radford-Smith, T Ahmad, CW Lees, T Balschun, J Lee, R Roberts, CA Anderson, JC Bis, S Bumpstead, D Ellinghaus, EM Festen, M Georges, T Green, T Haritunians, L Jostins, A Latiano, CG Mathew, GW Montgomery, NJ Prescott, S Raychaudhuri, JI Rotter, P Schumm, Y Sharma, LA Simms, KD Taylor, D Whiteman, C Wijmenga, RN Baldassano, M Barclay, TM Bayless, S Brand, C B&amp;uuml;ning, A Cohen, J-F Colombel, M Cottone, L Stronati, T Denson, M De Vos, R D'Inca, M Dubinsky, C Edwards, T Florin, D Franchimont, RGearry, J Glas, A Van Gossum, SL Guthery, J Halfvarson, HW Verspaget, J-P Hugot, A Karban, D Laukens, I Lawrance, M Lemann, A Levine, C Libioulle, E Louis, C Mowat, W Newman, J Pan&amp;eacute;s, A Phillips, DD Proctor, M Regueiro, R Russell, P Rutgeerts, J Sanderson, M Sans, FSeibold, AH Steinhart, PCF Stokkers, LTorkvist, G Kullak-Ublick, DC Wilson, T Walters, SR Targan, SR Brant, JD Rioux, M D'Amato, RK Weersma, S Kugathasan, AM Griffiths, JC Mansfield, S Vermeire, RH Duerr, MS Silverberg, J Satsangi, S Schreiber, JH Cho, V Annese, H Hakonarson, MJ Daly, M Parkes. Meta-Analysis Increases to 71 the Tally of Confirmed Crohn's Disease Susceptibility Loci. Nature Genetics 2010; 42: 1118-25 

Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, Lagace C, Scott R, Amininejad L, Bumpstead S, Baidoo L, Baldassano RN, Barclay M, Bayless TM, Brand S, Buning C, Colombel JF, Denson LA, de Vos M, Dubinsky M, Edwards C, Ellinghaus D, Fehrmann RSN, Floyd JAB, Florin T, Franchimont D, Franke L, Georges M, Glas J, Glazer NL, Guthery SL, Haritunians T, Hayward NK, Hugot JP, Jobin G, Laukens D, Lawrance I, Lemann M, Levine A, Libioulle C, Louis E, McGovern DP, Milla M, Montgomery GW, Morley KI, Mowat C, Ng A, Newman W, Ophoff RA, Papi L, Palmieri O, Peyrin-Biroulet L, Panes J, Phillips A, Prescott NJ, Proctor DD, Roberts R, Russell R, Rutgeerts P, Sanderson J, Sans M, Schumm P, Seibold F, Sharma Y, Simms LA, Seielstad M, Steinhart AH, Targan SR, van den Berg LH, Vatn M, Verspaget H, Walters T, Wijmenga C, Wilson DC, Westra HJ, Xavier RJ, Zhao ZZ, Ponsioen CY, Andersen V, Torkvist L, Gazouli M, Anagnou NP, Karlsen TH, Kupcinskas L, Sventoraityte J, Mansfield JC, Kugathasan S, Silverberg MS, Halfvarson J, Rotter JI, Mathew CG, Griffiths AM, Gearry R, Ahmad T, Brant SR, Chamaillard M, Satsangi J, Cho JH, Schreiber S, Daly MJ, Barrett JC, Parkes M, Annese V, Hakonarson H, Radford-Smith G, Duerr RH, Vermeire S, Weersma RK, Rioux JD. Metaanalysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nature Genetics 2011;43: 246-252.</gtr:impact><gtr:outcomeId>11C940B1FC1-1</gtr:outcomeId><gtr:partnerContribution>Data analysis, performance of IBD GWAS, meta-analyses of IBD GWAS, intellectual input</gtr:partnerContribution><gtr:piContribution>Data sharing, intellectual input</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Paediatric IBD departments</gtr:department><gtr:description>UK and Irish Paediatric IBD genetics group</gtr:description><gtr:id>813BB3F1-0B60-4B84-AF4B-7889D01FFF0A</gtr:id><gtr:impact>First experiment underway - 650 of 720 PICTS DNA samples submitted for international immunochip experiment; data collection commenced in collaborating centres; Analysis underway, 1st abstract published, 1st manuscript submitted 11/2011 to Nature Genetics.</gtr:impact><gtr:outcomeId>VdXmJKskAX5-1</gtr:outcomeId><gtr:partnerContribution>They will widen translational paediatric IBD research from Scotland to 6 selected centres in England plus Dublin, Ireland</gtr:partnerContribution><gtr:piContribution>I am lead of this UK and Irish paediatric IBD genetics group, a new constituent part of the UK IBD genetics consortium, and have attracted external funding as PI to form the paediatric group.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal College of Paediatrics and Child Health (RCPCH)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>British Society of Paediatric Gastroenterology, Hepatology and Nutrition</gtr:department><gtr:description>BSPGHAN Quality Initiative</gtr:description><gtr:id>849FC797-AD1E-4C91-8BB7-4BE1CD046903</gtr:id><gtr:impact>Only just commenced.</gtr:impact><gtr:outcomeId>R5Ugd4gbf7L-1</gtr:outcomeId><gtr:partnerContribution>I lead this UK wide initiative for quality (safety, effectiveness, patient experience) in children and teenagers receiving biological therapy for paediatric IBD. All other 25 Paediatric IBD centres in UK will submit patient details, salivary DNA, questionairres, to our centre in Edinburgh, and allow a nationwide patient registry and DNA bank. I am PI on this grouping and received external grant funding in competitive application.</gtr:partnerContribution><gtr:piContribution>I lead this UK wide initiative for quality (safety, effectiveness, patient experience) in children and teenagers receiving biological therapy for paediatric IBD. All other 25 Paediatric IBD centres in UK will submit patient details, salivary DNA, questionairres, to our centre in Edinburgh, and allow a nationwide patient registry and DNA bank. I am PI on this grouping and received external grant funding in competitive application.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Presentation to UEGW on Thiopurine Withdrawal</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5B1A2A21-A519-456B-9FA1-37DCF1E097F3</gtr:id><gtr:impact>UEGW, Stockholm 2011. Well-attended oral presentation.

Kennedy NA, Gambles CJ, Musy RM, Jones GR, Arnott ID, Satsangi J, Lees CW. Predictive Factors of Disease Relapse Following Thiopurine Withdrawal for Sustained Clinical Remission of IBD.

We have subsequently presented this data at a British meeting and have extended the study to include other British sites. A paper is in progress.</gtr:impact><gtr:outcomeId>KvkfiXhC8Wh</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>DDW presentation on Mercaptopurine following Azathioprine</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>92EA85B5-92C1-4EA6-8C02-91260F891A98</gtr:id><gtr:impact>Well-attended oral presentation at DDW May 2012, San Diego (www.ddw.org).
Rhatigan EB, Kennedy NA, Arnott ID, Noble CL, Shand AG, Satsangi J, Lees CW. A Trial With Mercaptopurine Following Azathioprine Intolerance is a Safe Treatment Strategy for the Majority of Patients With IBD. DDW 2012. (Presentation prepared and given by Dr Kennedy.) Gastroenterology 2012;142:S-206.



Paper underway and will be submitted soon.</gtr:impact><gtr:outcomeId>QAe4yRwHhSz</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Guest Speaker University of Cork</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B5DE3065-D9E8-496A-B606-1B78C8EBDE6B</gtr:id><gtr:impact>Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2c1f52d0ed8.66990843</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Society of Gastroenterology Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2F7A938A-D9B6-4084-A17E-D18CA05D0742</gtr:id><gtr:impact>Nil</gtr:impact><gtr:outcomeId>kbQugfnEJ9S</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to a charity C3</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>34C411ED-6E68-4DA5-80D3-01EFE63BD026</gtr:id><gtr:impact>Board meeting attended by approx 10 people. Dr Kennedy presented his research to date which provoked interested discussion.

Expression of interest for possible further funding.</gtr:impact><gtr:outcomeId>JDLQETkcaVN</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NACC LECTURES</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>51B6FF97-C14C-441A-968C-301E77F4BAE3</gtr:id><gtr:impact>HEIGHTENED INTEREST AND AWARENESS OF ON-GOING RESEARCH WORK IN CROHN'S DISEASE

MEDIA INTEREST FOLLOWED.</gtr:impact><gtr:outcomeId>eY9pWtNSgRE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Swedish Gastrodagarna</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>48E20FB0-5F2C-4B08-9FD6-20638DE6031B</gtr:id><gtr:impact>Lecture given to conference in Orebo, Sweden, on 30 May 2013.

Nil</gtr:impact><gtr:outcomeId>d1G1Vh2G22Q</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media release October 2009 (joint Wellcome and NACC)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>882ED16A-1F6E-4F14-A200-693054A1BD0A</gtr:id><gtr:impact>Media release taken up by BBC News website, Scottish newspapers about our genetic paper published online in Nature Genetics in October 2009

Awareness raising</gtr:impact><gtr:outcomeId>DB4C386515C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EU IBD Character Meeting Barcelona Spain</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>15A0C9C4-A781-46EC-97C0-935FADE91A23</gtr:id><gtr:impact>Annual Meeting with collaborators throughout Europe and elsewhere. Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b96d4fd839.82211780</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EU IBD-BIOM Meeting in Dubrovnik Croatia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>223545D4-0C34-4FD3-A2B6-515CB8965B7C</gtr:id><gtr:impact>Annual EU BIOM Meeting with collaborators in Europe and elsewhere. Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b1044e9480.27099107</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Crohn's and Colitis UK (UK wide IBD charity) Scottish Family Day 2011</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>22F61141-C3CC-4844-A4C4-2212252F807E</gtr:id><gtr:impact>120 family members attended Edinburgh zoo, 4 presentations from our multidisciplinary team including research from MRC grant

Highly positive evaluations from families</gtr:impact><gtr:outcomeId>darsnL3aQqj</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CICRA (UK wide IBD charity) Annual Out of London Meeting 2009</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>464986E3-2AD1-4DE6-B24C-7B2AFEFC940D</gtr:id><gtr:impact>125 family members attended for a day of lectures and workshops.

Awareness raising, much interest from children with IBD and their families</gtr:impact><gtr:outcomeId>j1KNGsKwveM</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Falk Foundation Gastroenterology Study Day, Birmigham</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CB6500E0-BCE5-45D8-A0C6-54FD28BE56B7</gtr:id><gtr:impact>Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2af2f2be568.25528120</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Society of Gastroenterology Meeting in Liverpool</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5EBE855B-94D6-4DB0-A568-0C0E64300B88</gtr:id><gtr:impact>Giving a talk at the annual British Society of Gastroenterology Meeting. Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b809dd2da3.10820942</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NACC (UK wide IBD charity) Annual General Meeting 2010</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>357AEB33-D148-483D-8E73-1BE7CC7C80F1</gtr:id><gtr:impact>300 attendees, much interest.

Asked to extend research work from Scotland to NE England.</gtr:impact><gtr:outcomeId>BZUSRkpfgHS</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford Masterclass 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C10FD668-12C5-4A7F-8035-1360B3734671</gtr:id><gtr:impact>Giving talk at Oxford Masterclass Meeting - dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b8b5d16869.16779304</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to ABPI</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2A7DDC0F-076C-438B-B77D-D5731147A27A</gtr:id><gtr:impact>12 members of this Network attended, 11 from the pharmaceutical industry and the ABPI employed-secretary of the group.

Further details of research requested and passed on to other members of this network</gtr:impact><gtr:outcomeId>nifD3yb9DwF</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open Symposium EU Project Forum, Amsterdam, Netherlands</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1488C64B-FFBA-4B82-AEE2-0EAEA7D60931</gtr:id><gtr:impact>Collaborative Meeting for EU Collaborators during ECCO Amsterdam meeting. Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b05496dda4.84416639</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Crohn's and Colitis UK (UK wide IBD charity) Scottish Family Day 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A1501B21-F13E-492B-B03B-E94AF2D5172B</gtr:id><gtr:impact>Talk sparked multiple questions

More families wished to participate in our research</gtr:impact><gtr:outcomeId>5464d3bdee7282.31303354</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Falk IBD Meeting Birmingham</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DF9FADBE-9F7C-487E-AEA9-40ED3686645B</gtr:id><gtr:impact>Dr Falk Meeting 2016 - Disseminaton of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b9dc49adc4.14929342</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>20th Advanced Gastroenterology &amp; Hepatology Course, Royal College of Physicians of Edinburgh</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>396177B5-07C9-4572-8446-154737D0D57B</gtr:id><gtr:impact>Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2ad5a3bdc73.06353875</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK wide IBD charity (CICRA) - annual general meeting, London</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B113FB73-E037-41F7-8B1C-911264A43C39</gtr:id><gtr:impact>200 people at AGM, lots of questions and interest in answers

Awareness raising - plans to expand this cohort research from Scotland only to UK wide</gtr:impact><gtr:outcomeId>6F3330E4366</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Digestive Disease Week San Diego, California, USA</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6338622C-BCAD-4790-AEEB-0C2FC8EBDF39</gtr:id><gtr:impact>Presentation given at Digestive Disease Week, American Gastroenterology Association. Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b3077feac7.41568044</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient Group Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>02725AD2-1B13-4DA1-A612-1A6D52DD04CC</gtr:id><gtr:impact>65 patients with IBD and their carers attended a regional meeting and I explained our research and discussed advances. Very high ratings were obtained from the group.</gtr:impact><gtr:outcomeId>56e17da9cbe121.28287403</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to private charity - Cure Crohn's and Colitis organisation.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3C0F92DD-5649-4348-8D16-09DBAE4EAAA7</gtr:id><gtr:impact>Presentation to the Cure Crohn's and Colitis (C3) charity board members of current potential translational aspects of genetic work - including pharmacogenetics of corticosteroid response.


This has led to further involvement of C3 in co-funding further work in Edinburgh GI Unit - currently in the development of a national biobank of inflammatory bowel disease in Scotland. Funding of CSO was acknowledged.</gtr:impact><gtr:outcomeId>E9274eLHhYf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UNIVERSITY OF EDINBURGH, PUBLIC LECTURE, QUEENS MEDICAL RESEARCH INSTITUTE</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E8150D1D-0265-4E8D-A261-F8F1F9953771</gtr:id><gtr:impact>Dissemination of scientific knowledge and advances in patient care, to general public, clinicians, scientists.</gtr:impact><gtr:outcomeId>58c2c14c0420b7.14176393</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NACC (UK wide IBD charity) Scottish Family Day 2010</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>15966B25-2E27-4CF3-BF8C-540006166B85</gtr:id><gtr:impact>150 children and teenagers with IBD and family members present.

Much interest in science as applied to children, long term outcomes etc.</gtr:impact><gtr:outcomeId>WFk6nx97wbZ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CICRA IBD FAMILY INFORMATION DAY</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6E6717D5-F83E-4F55-82CE-1E00FC2F31C5</gtr:id><gtr:impact>Information given to families.

Increase in patient interest in research.</gtr:impact><gtr:outcomeId>551423a6ef8dc5.57728723</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to CCUK Charity April 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4AE0752A-70AA-418C-A440-1D135BCEB835</gtr:id><gtr:impact>200 delegates. Very positive feedback.

Nil</gtr:impact><gtr:outcomeId>ATqpN8vRtZR</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Society of Gastroenterology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E7F1BABF-77DE-414D-A826-5F966F16BD3B</gtr:id><gtr:impact>Discussion was stimulated.

Further research projects proposed.</gtr:impact><gtr:outcomeId>5460ee45a683a4.32230764</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University of Edinburgh Centre for Inflammation Research Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>37BC1244-E2F8-42AE-9C48-1530BE7AC5AA</gtr:id><gtr:impact>University of Edinburgh Internal Lecture. Dissemination of scientific knowledge.</gtr:impact><gtr:outcomeId>58c2b206a386f5.54564972</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release of ABCB5 transport as a mechanism of steroid resistance in inflammatory bowel disease.</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3EF97D43-CFE6-4906-B1D7-74C3B84720FC</gtr:id><gtr:impact>Following successful funding by National Association of Crohn's and Colitis (NACC) to further study the functional aspects of ABCB5 gene identified by the CSO-funded study, a press release was given - acknowledging the work which led to the discovery of these genes.

The press release achieved wide national dissemination and led to many inquiries from patient groups within/out of the field of inflammatory bowel disease.</gtr:impact><gtr:outcomeId>QNcxqYck9D7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Medical Research Foundation</gtr:department><gtr:description>Crohn's Disease Research Competition</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>B02936D1-8D32-4E12-825C-C1E350D8FCC7</gtr:id><gtr:outcomeId>5464c7ee794be6.93595873</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>99638</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MicroRNA profiling in Inflammatory Bowel Diseases: The application of Next Generation Sequencing</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>Crohn's and Colitis UK</gtr:fundingOrg><gtr:id>99B6C82E-7503-4214-A4C8-8AE531D443A9</gtr:id><gtr:outcomeId>58c298d32fef73.81206161</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>FP 7 EC IBD BIOM GRANT</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>305479-2</gtr:fundingRef><gtr:id>90ECC173-6257-4B1D-B4D3-9BCB7362CBB3</gtr:id><gtr:outcomeId>h6FyB2kHV2r</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>257684</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CSO PROJECT GRANT SUPPORT - EXPERIMENTAL &amp;amp; TRANSLATIONAL MEDCINE BOARD</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:fundingRef>ETM/137</gtr:fundingRef><gtr:id>9E9D840C-916B-4405-A87A-6C1B1719E88A</gtr:id><gtr:outcomeId>rbusLBvpbs50</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>647570</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR BioResource</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M00533X/1 Parkes</gtr:fundingRef><gtr:id>E3B32355-C20E-4F02-B47B-0FD3F6632A4F</gtr:id><gtr:outcomeId>55153520148af3.28366646</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>224998</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Grant Application</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:fundingRef>ETM/395</gtr:fundingRef><gtr:id>B8AF1BED-50CB-408F-8619-68DE0BDE9DD8</gtr:id><gtr:outcomeId>55153860d32a47.50379632</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>29914</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Sick Kids Friends Foundation</gtr:department><gtr:description>Sick Kids Friends Foundation (Royal Hospital for Sick Children in Edinburgh Charity)</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Royal Hospital for Sick Children Edinburgh</gtr:fundingOrg><gtr:id>AB8499A1-87AB-4CAB-878E-AA66A948D88A</gtr:id><gtr:outcomeId>KFXk9NZzpFR0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5975589</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Horizon 2020 - Research and Innovation Framework Programme</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>PHC-13-2014</gtr:fundingRef><gtr:id>A6BFD8DE-D222-419C-A31C-665A7F6F93DF</gtr:id><gtr:outcomeId>5515362aac4e30.83818928</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5975589</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>New Therapies for chronic non-communicable diseases - BIOCYLE</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>0FE29265-9004-403A-9B16-D313691BBCB2</gtr:id><gtr:outcomeId>56d70e64f41235.09555492</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EC FP7</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>59971D2A-2137-4168-ABBF-FD0DB319836A</gtr:id><gtr:outcomeId>M8AMYfYqpQK</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Edinburgh GI Trustees</gtr:description><gtr:fundingOrg>University of Edinburgh</gtr:fundingOrg><gtr:id>E0C0BBA0-6C80-481D-9A68-EC4BC0C3BDF0</gtr:id><gtr:outcomeId>550c0e098c54c7.85763277</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>34712</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CICRA annual research awards 2010</gtr:description><gtr:end>2014-11-02</gtr:end><gtr:fundingOrg>Crohn's in Childhood Research Association (CICRA)</gtr:fundingOrg><gtr:id>6270629D-7A95-4DA1-81D9-6B3F58B5FDEA</gtr:id><gtr:outcomeId>SNiCGZvm2bZ0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>26858</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CORE and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) Development Grant</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>CORE Charity</gtr:fundingOrg><gtr:id>EE84D1AC-7F9B-4D4B-BADD-4B8525B1A882</gtr:id><gtr:outcomeId>56e17cfd497a58.74207994</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2738767</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC CLINICAL TRIALS GRANT</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0600329</gtr:fundingRef><gtr:id>7A25649B-033A-43DA-B862-511A30B15B85</gtr:id><gtr:outcomeId>ZL7BzUJE6Ex0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>National Association of Crohn's and Colitis Project Grant</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>National Association for Colitis and Crohn?s Disease (NACC)</gtr:fundingOrg><gtr:id>AE4497EB-15B1-4591-9AB9-AA151CB70FAD</gtr:id><gtr:outcomeId>ZdVwCZRKydU0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NACC Research Grant Awards 2010</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>National Association for Colitis and Crohn?s Disease (NACC)</gtr:fundingOrg><gtr:fundingRef>M/11/01</gtr:fundingRef><gtr:id>7A0172D3-C0D1-483E-96C2-15F8919D6039</gtr:id><gtr:outcomeId>oR4K7TXZtbT0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Medical Research Foundation</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>Mason Medical Research Foundation</gtr:fundingOrg><gtr:id>592E969B-B371-452F-9710-FCB69677A9C0</gtr:id><gtr:outcomeId>56e17c3554d183.55160190</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>251648</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Clinical Research Training Fellowship</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>09743/Z/11/Z</gtr:fundingRef><gtr:id>880FF74B-FC7E-4D3A-8E35-555B73627FD3</gtr:id><gtr:outcomeId>N1hvWiYohWb</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>FP7 EC IBD CHARACTER</gtr:description><gtr:end>2015-11-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>305676-2</gtr:fundingRef><gtr:id>12F6AB41-8CA9-47FD-B862-5E67C39DBC44</gtr:id><gtr:outcomeId>d2UXTjnoB6x</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>106000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CICRA Research Training Fellowship</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>Crohn's in Childhood Research Association (CICRA)</gtr:fundingOrg><gtr:id>7864590F-C616-42C2-A354-FD0C875F4A96</gtr:id><gtr:outcomeId>JdjD5uPDgQz</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>22500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Network Grant</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)</gtr:fundingOrg><gtr:id>A53F7C0A-FBE4-4AC6-900A-7BE8FFCF1E84</gtr:id><gtr:outcomeId>56e17c9e724f86.11283953</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BRITISH SOCIETY OF GASTROENTEROLOGY IBD GUIDELINES</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EBC9B42A-94A8-42E8-A1BC-A90B7B2D8FCE</gtr:id><gtr:outcomeId>kjQBYrVoUSn</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have compiled the largest database of corticosteroid response in newly diagnosed patients with IBD across a 13-year period in Lothian.</gtr:description><gtr:id>6C47BDAC-22B3-46D0-83BB-C9EFDD0A4462</gtr:id><gtr:impact>Further clinical studies to longitudinally study the clinical outcomes of this cohort have been performed and results presented in national and international meetings.</gtr:impact><gtr:outcomeId>RAoGJdwBZba</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Database of 13-year inception cohort of corticosteroid outcome in IBD.</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Phenotyping of paediatric IBD with relation to response outcomes to corticosteroids. The objective is to study pharmacogenetic contribution of ABCB5 gene to this clinical end-point.</gtr:description><gtr:id>A7A65385-C0E6-439F-A22F-8525CA982953</gtr:id><gtr:impact>Still in progress.</gtr:impact><gtr:outcomeId>axDiPngEyEM</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Paediatric IBD Scottish Cohort</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F0C86229-3408-463A-89FA-FDEFD728DF17</gtr:id><gtr:title>Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3973f4184be66ec3d0d2394aae288cc3"><gtr:id>3973f4184be66ec3d0d2394aae288cc3</gtr:id><gtr:otherNames>Cleynen I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>56e171df94fcf1.46782310</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94D04302-E704-4D3A-BA9E-84D98E952E09</gtr:id><gtr:title>Editorial: what can be done when infliximab stops working in ulcerative colitis?</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28b1a25bedef401550366563cc3c49fc"><gtr:id>28b1a25bedef401550366563cc3c49fc</gtr:id><gtr:otherNames>Boyapati RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>58c132fb362a60.69731705</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EED10EF-B402-4187-B6F2-94E6811F6D39</gtr:id><gtr:title>Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/634fc019719cff5c15842e6960bd2bd7"><gtr:id>634fc019719cff5c15842e6960bd2bd7</gtr:id><gtr:otherNames>Ellinghaus D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5aaa62d9c4a215.36023137</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01EEFAF0-8DE2-47B1-9F09-9CE15896C537</gtr:id><gtr:title>Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Journal of Crohn's &amp; colitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f141aecadb6cd653faa2dcadec633f60"><gtr:id>f141aecadb6cd653faa2dcadec633f60</gtr:id><gtr:otherNames>Ruemmele FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1873-9946</gtr:issn><gtr:outcomeId>56e1747b000ff3.28464959</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4106CBFE-6F75-46EA-8A03-30C94D636544</gtr:id><gtr:title>A comprehensive evaluation of colonic mucosal isolates of Sutterella wadsworthensis from inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/722af0128dd76befcd7920473a7ec52e"><gtr:id>722af0128dd76befcd7920473a7ec52e</gtr:id><gtr:otherNames>Mukhopadhya I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_55f984984be6f9f4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03067466-6D77-4D5D-9CDC-C4BFEBD324B8</gtr:id><gtr:title>Genome-wide and fine-resolution association analysis of malaria in West Africa.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f21f1d98cd7f57fabc7b6af7b890e47"><gtr:id>5f21f1d98cd7f57fabc7b6af7b890e47</gtr:id><gtr:otherNames>Jallow M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>bWdSFdEN5PP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09F449DE-0269-488B-A706-E5A98FAB4553</gtr:id><gtr:title>Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>pm_16612_22_22221081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>633C3F33-4CAC-424C-8CFC-FBED55910589</gtr:id><gtr:title>Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61679ec8c97393a31d71ea64b48eb8c7"><gtr:id>61679ec8c97393a31d71ea64b48eb8c7</gtr:id><gtr:otherNames>Torres J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>56d591b51958b1.93000793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>486773A2-F9CB-462D-8B64-DC2E21C495D9</gtr:id><gtr:title>Systematic review: MRI enterography for assessment of small bowel involvement in paediatric Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f6c7108da6768e923ccafe7dd90561f"><gtr:id>9f6c7108da6768e923ccafe7dd90561f</gtr:id><gtr:otherNames>Giles E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>QcKzWL1zSp5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B52E4363-BE50-4C6E-B079-AF6AC5FE0F6F</gtr:id><gtr:title>Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a255a9d973fc3e59f2dbd0ef03280b76"><gtr:id>a255a9d973fc3e59f2dbd0ef03280b76</gtr:id><gtr:otherNames>Franke A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>Xsu7ouyhsWq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83925887-945D-4BEE-8CDD-E6305ACF575C</gtr:id><gtr:title>Surgical Management of Crohn Disease in Children: Guidelines From the Paediatric IBD Porto Group of ESPGHAN.</gtr:title><gtr:parentPublicationTitle>Journal of pediatric gastroenterology and nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35ce8eb225ca17033a2d5a04782d37a2"><gtr:id>35ce8eb225ca17033a2d5a04782d37a2</gtr:id><gtr:otherNames>Amil-Dias J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0277-2116</gtr:issn><gtr:outcomeId>58d1517677d0f4.40954271</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>780C81D3-7D91-46C8-AFCC-CD7485932D71</gtr:id><gtr:title>Faecal calprotectin in suspected paediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Journal of pediatric gastroenterology and nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f3ed72eb0310c344219818cdde80a61"><gtr:id>3f3ed72eb0310c344219818cdde80a61</gtr:id><gtr:otherNames>Degraeuwe PL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0277-2116</gtr:issn><gtr:outcomeId>5464c174dde4f4.55070125</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A405744-B555-443E-B3E7-C1AD790F7257</gtr:id><gtr:title>The role of glycosylation in IBD.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddf6086ff1060ed1c3c1158b9e0085f5"><gtr:id>ddf6086ff1060ed1c3c1158b9e0085f5</gtr:id><gtr:otherNames>Theodoratou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-5045</gtr:issn><gtr:outcomeId>545a3a6f3ff890.55433425</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3583C13B-E7B8-4A36-A15C-EB4F638449E9</gtr:id><gtr:title>A retrospective study showing maintenance treatment options for paediatric CD in the first year following diagnosis after induction of remission with EEN: supplemental enteral nutrition is better than nothing!</gtr:title><gtr:parentPublicationTitle>BMC gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31f92f8673538d0a5e0c9be6130e227f"><gtr:id>31f92f8673538d0a5e0c9be6130e227f</gtr:id><gtr:otherNames>Duncan H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-230X</gtr:issn><gtr:outcomeId>doi_55f984984bde5809</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1310C453-5A43-44C3-82CE-0478A2CD6843</gtr:id><gtr:title>A role for vimentin in Crohn disease.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>pm_16612_22_22929019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94BDEF9E-77CB-423F-A5C1-5319F3D6B6B7</gtr:id><gtr:title>Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c601a805f173a4991f1b619667ca44c2"><gtr:id>c601a805f173a4991f1b619667ca44c2</gtr:id><gtr:otherNames>Dehghan A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1942-3268</gtr:issn><gtr:outcomeId>QhstBYADDqk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C30634E6-22F5-47A6-856B-8AACD36256F9</gtr:id><gtr:title>Genome-wide association study identifies eight loci associated with blood pressure.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15b00f9f5513473e8bd79455323c1869"><gtr:id>15b00f9f5513473e8bd79455323c1869</gtr:id><gtr:otherNames>Newton-Cheh C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>i65KQEkNbTC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A57CAD8-9265-4959-85FD-F37654A297CE</gtr:id><gtr:title>Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eceaa0d8d49922665570d609c2586922"><gtr:id>eceaa0d8d49922665570d609c2586922</gtr:id><gtr:otherNames>Villani AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>eA23k547AvY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07E2AC0F-7D21-44E0-A007-DB639EA39C0E</gtr:id><gtr:title>Negligible impact of rare autoimmune-locus coding-region variants on missing heritability.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28d5e44cfd0fb461260062e89bab9868"><gtr:id>28d5e44cfd0fb461260062e89bab9868</gtr:id><gtr:otherNames>Hunt KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_15892_22_23698362</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36BA0A17-B7A8-4279-9464-FDFF30F397C7</gtr:id><gtr:title>Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c5db92b3cd994f383d1bd62191511d"><gtr:id>90c5db92b3cd994f383d1bd62191511d</gtr:id><gtr:otherNames>Cross-Disorder Group of the Psychiatric Genomics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>56e176137a9044.49157627</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27A02516-5694-4136-B04C-D007B1C64B2B</gtr:id><gtr:title>Barrett's esophagus: evolutionary insights from genomics.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7a0fca0f1cd8e8bab752542f949f6f1"><gtr:id>d7a0fca0f1cd8e8bab752542f949f6f1</gtr:id><gtr:otherNames>Jankowski JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>545a42436180e7.64238568</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B07F8A2D-A9F9-424C-A21F-779DCDF699BE</gtr:id><gtr:title>HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fb8b35143d2c3224157d16285969e98"><gtr:id>4fb8b35143d2c3224157d16285969e98</gtr:id><gtr:otherNames>Heap GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>545a3952b8b943.68422211</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F18BA54-52B4-49D1-9097-F80F6979D11A</gtr:id><gtr:title>Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c83ed689c5a5ce62539b156194e47f43"><gtr:id>c83ed689c5a5ce62539b156194e47f43</gtr:id><gtr:otherNames>Reilly MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>Ni7cU9suXYP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77639FEC-B6DD-44BD-935B-315A54F0DFBB</gtr:id><gtr:title>Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8e45c11ff8b196523502e41d8ce46cf"><gtr:id>c8e45c11ff8b196523502e41d8ce46cf</gtr:id><gtr:otherNames>Anderson CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>hcF3B9AnYss</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77243B8F-FF2B-4FF7-9C59-A31C2F5B7DCA</gtr:id><gtr:title>Comparison of mortality following hospitalisation for ulcerative colitis in Scotland between 1998-2000 and 2007-2009.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be7f3c9c818fb8f7c8a3e8507c421eed"><gtr:id>be7f3c9c818fb8f7c8a3e8507c421eed</gtr:id><gtr:otherNames>Ventham NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>545a3aa061ff96.94802206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9878DA11-C715-4C76-A48C-85BB26AE768C</gtr:id><gtr:title>Recent advances in paediatric gastroenterology.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31abd3bea412764d82c7a0bb6e35fa73"><gtr:id>31abd3bea412764d82c7a0bb6e35fa73</gtr:id><gtr:otherNames>Hansen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>5675e01268201</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71F28765-8801-43E4-8157-2CFF6D30B853</gtr:id><gtr:title>ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents.</gtr:title><gtr:parentPublicationTitle>Journal of pediatric gastroenterology and nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0235215fca67ee52073d2e8888833cc"><gtr:id>f0235215fca67ee52073d2e8888833cc</gtr:id><gtr:otherNames>Levine A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0277-2116</gtr:issn><gtr:outcomeId>PmnXPCSHSA7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98DED384-8DEB-4981-9C88-D7FE7CCD3F6D</gtr:id><gtr:title>Development and Validation of Diagnostic Criteria for IBD Subtypes Including IBD-unclassified in Children: a Multicentre Study From the Pediatric IBD Porto Group of ESPGHAN.</gtr:title><gtr:parentPublicationTitle>Journal of Crohn's &amp; colitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19956025010c7cc0e142741034f526e9"><gtr:id>19956025010c7cc0e142741034f526e9</gtr:id><gtr:otherNames>Birimberg-Schwartz L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1873-9946</gtr:issn><gtr:outcomeId>5aaa63864738c3.02310255</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBCC17B5-DFF7-4E84-BF07-BF0D94BBCBB3</gtr:id><gtr:title>Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysis.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/370760c2b2beee5cc61a02c9e4c3e85c"><gtr:id>370760c2b2beee5cc61a02c9e4c3e85c</gtr:id><gtr:otherNames>Noble CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>D14VDuf6TmE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49BCAA5D-8578-4B86-B761-7B4E647F7DA3</gtr:id><gtr:title>Autophagy: from basic science to clinical application.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f444492accbb6a473246d6fe44c8a127"><gtr:id>f444492accbb6a473246d6fe44c8a127</gtr:id><gtr:otherNames>Van Limbergen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>D1B5A29AD94</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>719D3794-F887-4B9C-A0FD-8CD40FE9DED5</gtr:id><gtr:title>Systematic review: The use of thiopurines or anti-TNF in post-operative Crohn's disease maintenance--progress and prospects.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc5db65cb0365641c12089dcf2c6679e"><gtr:id>cc5db65cb0365641c12089dcf2c6679e</gtr:id><gtr:otherNames>Jones GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>545a3ac6873c19.13605249</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>422B4A33-5BB5-49C3-9AB0-03F1F72CDDDF</gtr:id><gtr:title>Real-Life Anti-Tumour Necrosis Factor Experience in &amp;gt; 500 Paediatric United Kingdom Inflammatory Bowel Disease Patients.</gtr:title><gtr:parentPublicationTitle>Journal of pediatric gastroenterology and nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50a722c4defaca0e2f7b7ed7b7458ce5"><gtr:id>50a722c4defaca0e2f7b7ed7b7458ce5</gtr:id><gtr:otherNames>Merrick VM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0277-2116</gtr:issn><gtr:outcomeId>5aaa64e7e97511.04903089</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23C37ADF-DF94-411E-9D75-8CF59E05EBF6</gtr:id><gtr:title>Nationwide linkage analysis in Scotland implicates age as the critical overall determinant of mortality in ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34b818d5cf371312cf412804af2f7353"><gtr:id>34b818d5cf371312cf412804af2f7353</gtr:id><gtr:otherNames>Nicholls RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>ePaaFtDq1TN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63961796-DF74-4D7D-AE12-D15F3BE2E0ED</gtr:id><gtr:title>A common biological basis of obesity and nicotine addiction.</gtr:title><gtr:parentPublicationTitle>Translational psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60115f8ea005e2a184f16c4d64088d52"><gtr:id>60115f8ea005e2a184f16c4d64088d52</gtr:id><gtr:otherNames>Thorgeirsson TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2158-3188</gtr:issn><gtr:outcomeId>545a3c2e3f1d06.17321649</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>037D2086-412A-43CB-A1AD-6DE1CD1DBD8E</gtr:id><gtr:title>Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8e45c11ff8b196523502e41d8ce46cf"><gtr:id>c8e45c11ff8b196523502e41d8ce46cf</gtr:id><gtr:otherNames>Anderson CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>N6z2etrz5iU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>272BB574-98AE-4F82-855E-3D1F25891FC1</gtr:id><gtr:title>Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history.</gtr:title><gtr:parentPublicationTitle>Expert review of gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bd368253fec639b465fd164d29cb2ba"><gtr:id>2bd368253fec639b465fd164d29cb2ba</gtr:id><gtr:otherNames>Lees CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1747-4124</gtr:issn><gtr:outcomeId>PqgaULSxffD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E70CD410-C3E3-4FF0-BA10-7ACEA721F659</gtr:id><gtr:title>Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43d0d23737bcf164813e93f774577d3e"><gtr:id>43d0d23737bcf164813e93f774577d3e</gtr:id><gtr:otherNames>UK IBD Genetics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>beJZ58q5Qjj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>742B2A88-2527-4C4A-9448-7E0E1BF6D6F0</gtr:id><gtr:title>Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f5948b5a7f162e349b3184da5420ba0"><gtr:id>5f5948b5a7f162e349b3184da5420ba0</gtr:id><gtr:otherNames>Wang K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>mCjqua54px2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41D59D75-32F6-4FB5-8EBF-7341B2F6AA9E</gtr:id><gtr:title>Management of Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b83a9614183474a838d8cd9ab297f54"><gtr:id>9b83a9614183474a838d8cd9ab297f54</gtr:id><gtr:otherNames>Kammermeier J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>585d55c44d4b87.01895834</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>963346EB-0E9A-45C3-AA9C-9550B07D87F3</gtr:id><gtr:title>Contemporary outcomes for ulcerative colitis inpatients admitted to pediatric hospitals in the United Kingdom.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58e9b7843c867fa71473bb98977691f6"><gtr:id>58e9b7843c867fa71473bb98977691f6</gtr:id><gtr:otherNames>Russell RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>56e1772572c909.43076876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69DA1CBB-79A8-4603-BAF8-4800522A8266</gtr:id><gtr:title>PepT1 oligopeptide transporter (SLC15A1) gene polymorphism in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd29fe15ac25ec5c0474193a1330a56f"><gtr:id>bd29fe15ac25ec5c0474193a1330a56f</gtr:id><gtr:otherNames>Zucchelli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>MacSUQoiaE8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FE2D7B9-886C-49A3-9BCE-C727612E04FA</gtr:id><gtr:title>MicroRNAs: new players in IBD.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7cfe472cce65a6e4c1409d62261cbc1"><gtr:id>a7cfe472cce65a6e4c1409d62261cbc1</gtr:id><gtr:otherNames>Kalla R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>551048bcdb3910.90856244</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35CC988E-023B-4231-B028-4B6798B66A77</gtr:id><gtr:title>Common variants at five new loci associated with early-onset inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a4163f30dfab1ea4a2d31101fa14e36"><gtr:id>5a4163f30dfab1ea4a2d31101fa14e36</gtr:id><gtr:otherNames>Imielinski M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>BDE06557265</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DACD224-020B-4E7D-823A-4CC28A23F5A8</gtr:id><gtr:title>Novel loci associated with increased risk of sudden cardiac death in the context of coronary artery disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9990519301f803df7f03605aaaeeab3"><gtr:id>b9990519301f803df7f03605aaaeeab3</gtr:id><gtr:otherNames>Huertas-Vazquez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15892_22_23593153</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3BAD60D-9881-4EFB-BC34-AEC44E3C3967</gtr:id><gtr:title>Correction: changes to serum sample tube and processing methodology does not cause inter-individual variation in automated whole serum N-glycan profiling in health and disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be7f3c9c818fb8f7c8a3e8507c421eed"><gtr:id>be7f3c9c818fb8f7c8a3e8507c421eed</gtr:id><gtr:otherNames>Ventham NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58b95f2f4c7bb1.33080033</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BE57717-C769-4D36-9417-26C88290CD72</gtr:id><gtr:title>A British Society of Paediatric Gastroenterology, Hepatology and Nutrition survey of the effectiveness and safety of adalimumab in children with inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58e9b7843c867fa71473bb98977691f6"><gtr:id>58e9b7843c867fa71473bb98977691f6</gtr:id><gtr:otherNames>Russell RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>kqg4MGvWnE8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F94E86A-AE6B-42CE-92CE-78A0B7669D36</gtr:id><gtr:title>Copy number variation of scavenger-receptor cysteine-rich domains within DMBT1 and Crohn's disease.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8572e735ea379400c17eb20c116ef05a"><gtr:id>8572e735ea379400c17eb20c116ef05a</gtr:id><gtr:otherNames>Polley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>58b95f2e776cc6.58148849</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F0E74B8-4A11-4F69-A5F9-6208657952AD</gtr:id><gtr:title>Genetics of childhood-onset inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>cEwb2xTq37R</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03DEE159-AB9E-4963-9E93-83992C906348</gtr:id><gtr:title>Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e2d0947beef3a4da746fc9d89cbb670"><gtr:id>0e2d0947beef3a4da746fc9d89cbb670</gtr:id><gtr:otherNames>Turner D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>5464c21c2ae6c3.05485653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE543EC5-7C20-4A8D-98E4-E9B909BA8E18</gtr:id><gtr:title>Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and immunochip data.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec6d3af19cb069864e282d238103313e"><gtr:id>ec6d3af19cb069864e282d238103313e</gtr:id><gtr:otherNames>Chen GB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>56e17613e331e8.49858625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>600E9D19-AFCD-4C86-BE89-7ADAD76DC0CD</gtr:id><gtr:title>Meta-analysis and imputation refines the association of 15q25 with smoking quantity.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f08243406518279380370a3fd236f37"><gtr:id>4f08243406518279380370a3fd236f37</gtr:id><gtr:otherNames>Liu JZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>MrXP8LbMej3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50DF9503-91C7-4BAE-9EE2-E602AA2B8C92</gtr:id><gtr:title>The intermediate filament protein, vimentin, is a regulator of NOD2 activity.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e44fcfb9fb3237b0ce7a55d7295b2a46"><gtr:id>e44fcfb9fb3237b0ce7a55d7295b2a46</gtr:id><gtr:otherNames>Stevens C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>pm_16612_22_22684479</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8935FDAD-A660-46F4-9A87-DA6C6C5F4806</gtr:id><gtr:title>Malignancy and mortality in pediatric patients with inflammatory bowel disease: a multinational study from the porto pediatric IBD group.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7055cca49e1a56ac22042aa61c554ca"><gtr:id>a7055cca49e1a56ac22042aa61c554ca</gtr:id><gtr:otherNames>de Ridder L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>5464c06c7296a1.21813672</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE4E360D-4AFD-463A-85CC-17805585EBF6</gtr:id><gtr:title>Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8ba377304d5e7fd1f2b7d997300293a"><gtr:id>c8ba377304d5e7fd1f2b7d997300293a</gtr:id><gtr:otherNames>Nimmo ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>ZM8sSjJ1Zsk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA171B65-4E1F-42D8-AE49-00D39A21D164</gtr:id><gtr:title>Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e051e9782b413d28b51dac97e8d57905"><gtr:id>e051e9782b413d28b51dac97e8d57905</gtr:id><gtr:otherNames>Rossin EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>q5MYtgvmNDd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87708102-5903-4475-8050-CDA1C8BA8AB2</gtr:id><gtr:title>Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f5948b5a7f162e349b3184da5420ba0"><gtr:id>5f5948b5a7f162e349b3184da5420ba0</gtr:id><gtr:otherNames>Wang K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>k7reDaGbBdq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D4BE42B-7676-4ABF-8EF6-9E51A5776D56</gtr:id><gtr:title>Predicting outcomes in acute severe ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Expert review of gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be7f3c9c818fb8f7c8a3e8507c421eed"><gtr:id>be7f3c9c818fb8f7c8a3e8507c421eed</gtr:id><gtr:otherNames>Ventham NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1747-4124</gtr:issn><gtr:outcomeId>5510489c4edd14.86491520</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B511085D-9A9E-4C43-89CA-12999A49BEB4</gtr:id><gtr:title>High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f44301104351bc4e4ca5a598859ccee4"><gtr:id>f44301104351bc4e4ca5a598859ccee4</gtr:id><gtr:otherNames>Goyette P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>56e172e6659ac1.55390265</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA0C57A1-8C6B-4D38-917C-1DCA0800F6AE</gtr:id><gtr:title>Bayesian refinement of association signals for 14 loci in 3 common diseases.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a32e5e38a8b83514d902fbe4626b80ee"><gtr:id>a32e5e38a8b83514d902fbe4626b80ee</gtr:id><gtr:otherNames>Wellcome Trust Case Control Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_15892_22_23104008</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D497997-F7E3-478D-9A72-1DF0C6293F29</gtr:id><gtr:title>Genes in inflammatory bowel disease: lessons from complex diseases.</gtr:title><gtr:parentPublicationTitle>Clinical medicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1470-2118</gtr:issn><gtr:outcomeId>pm_16612_22_21404774</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>113A3861-A9D9-458A-87D1-714415CF873B</gtr:id><gtr:title>Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines.</gtr:title><gtr:parentPublicationTitle>Journal of pediatric gastroenterology and nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e2d0947beef3a4da746fc9d89cbb670"><gtr:id>0e2d0947beef3a4da746fc9d89cbb670</gtr:id><gtr:otherNames>Turner D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0277-2116</gtr:issn><gtr:outcomeId>pm_16612_22_22773060</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57A541AB-38CA-47FC-977E-7BF5F69CEE24</gtr:id><gtr:title>The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bd368253fec639b465fd164d29cb2ba"><gtr:id>2bd368253fec639b465fd164d29cb2ba</gtr:id><gtr:otherNames>Lees CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>Q89Qmm4RUEy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BA41068-63C0-4300-A96C-91C444039490</gtr:id><gtr:title>Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50e6243a98509e54910c6932cb74b8db"><gtr:id>50e6243a98509e54910c6932cb74b8db</gtr:id><gtr:otherNames>Lee JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58d1517708cc47.51615832</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C360A5D2-9EB8-4B21-A4DE-931F83F14383</gtr:id><gtr:title>Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control study.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c1396e262f01d61d4d04461debba360"><gtr:id>3c1396e262f01d61d4d04461debba360</gtr:id><gtr:otherNames>Andersen V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>Rurfy2dphrC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97B43140-DD59-4CC3-8843-F7132AB3EB49</gtr:id><gtr:title>Tuberous sclerosis-2 (TSC2) regulates the stability of death-associated protein kinase-1 (DAPK) through a lysosome-dependent degradation pathway.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df1446d37ddbc9ae923008079c6a1ce3"><gtr:id>df1446d37ddbc9ae923008079c6a1ce3</gtr:id><gtr:otherNames>Lin Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>pm_16612_22_21134130</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A74E8C4A-C91D-4CDF-9A0B-35E903FB9B81</gtr:id><gtr:title>Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d48c2365018bf37692689d84ad467a48"><gtr:id>d48c2365018bf37692689d84ad467a48</gtr:id><gtr:otherNames>Beaudoin M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_15892_22_24068945</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>972676FA-7FCD-475A-956A-B7F331667CAB</gtr:id><gtr:title>Multiple sclerosis in the context of TNF blockade and inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33800cbdd8ec2b7e624dd14dad808264"><gtr:id>33800cbdd8ec2b7e624dd14dad808264</gtr:id><gtr:otherNames>Hare NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>pm_15892_22_22240391</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17631FA3-AB65-491E-BC96-6E2A92DC1708</gtr:id><gtr:title>New IBD genetics: common pathways with other diseases.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bd368253fec639b465fd164d29cb2ba"><gtr:id>2bd368253fec639b465fd164d29cb2ba</gtr:id><gtr:otherNames>Lees CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>daGJcP4s521</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A302C85-A143-44EE-B594-7B3421B62C32</gtr:id><gtr:title>Predicting the need for colectomy in severe ulcerative colitis: a critical appraisal of clinical parameters and currently available biomarkers.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4e64c34aaae304b77559843fb6dcff8"><gtr:id>a4e64c34aaae304b77559843fb6dcff8</gtr:id><gtr:otherNames>Travis S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>FTNa5Z8kbLx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E6AF080-381C-46D2-ABEB-D018CD8CF962</gtr:id><gtr:title>Detailed haplotype-tagging study of germline variation of MUC19 in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c03c031f93314568064c52c650a9dae9"><gtr:id>c03c031f93314568064c52c650a9dae9</gtr:id><gtr:otherNames>Phillips AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>pKTBbsdGKGu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06F75F6C-128D-4D47-AB18-3B9C4A3EF74D</gtr:id><gtr:title>Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41592addbe7ed7bd4bb66e0747bf25b4"><gtr:id>41592addbe7ed7bd4bb66e0747bf25b4</gtr:id><gtr:otherNames>Gerasimidis K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>doi_55f984984bc18669</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B4F7589-1805-4C3A-94E2-E0017722136A</gtr:id><gtr:title>The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>The American journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-9270</gtr:issn><gtr:outcomeId>pm_16612_22_22370604</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B98B7A2-785C-456A-AE20-EF494BE846FD</gtr:id><gtr:title>Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1605ad728ecb6d5cabf79b7add99fc60"><gtr:id>1605ad728ecb6d5cabf79b7add99fc60</gtr:id><gtr:otherNames>Li YR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>56e171e0108d35.83480578</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EB14B80-7288-4F87-8BC0-8BB111E853EF</gtr:id><gtr:title>TLE1 modifies the effects of NOD2 in the pathogenesis of Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8ba377304d5e7fd1f2b7d997300293a"><gtr:id>c8ba377304d5e7fd1f2b7d997300293a</gtr:id><gtr:otherNames>Nimmo ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>Ge6F4huGyat</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D921F607-75A9-4470-AD37-F0AE908B6B02</gtr:id><gtr:title>Danish cohort of monozygotic inflammatory bowel disease twins: Clinical characteristics and inflammatory activity.</gtr:title><gtr:parentPublicationTitle>World journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e504e6f1ba46486879fb5b5cedf84836"><gtr:id>e504e6f1ba46486879fb5b5cedf84836</gtr:id><gtr:otherNames>Moller FT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1007-9327</gtr:issn><gtr:outcomeId>58b95f2d5cb1c0.79881372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>120FE9DD-A64E-4CD6-8DEB-FBFE8B55D11A</gtr:id><gtr:title>Pathogenesis of Crohn's disease.</gtr:title><gtr:parentPublicationTitle>F1000prime reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d303a6716833659b362d79806b3d7355"><gtr:id>d303a6716833659b362d79806b3d7355</gtr:id><gtr:otherNames>Boyapati R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2051-7599</gtr:issn><gtr:outcomeId>56d5925b5ccb62.11605424</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F31D617D-E59E-4291-BEAF-1E673132F5C0</gtr:id><gtr:title>Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f141aecadb6cd653faa2dcadec633f60"><gtr:id>f141aecadb6cd653faa2dcadec633f60</gtr:id><gtr:otherNames>Ruemmele FM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>5464c17534c3b0.06304493</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CEDD2D4-6812-4A5B-9D17-0B96A70FDC18</gtr:id><gtr:title>Sarcoidosis complicating treatment with natalizumab for Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bffe2c88e0743de298720c2901b77790"><gtr:id>bffe2c88e0743de298720c2901b77790</gtr:id><gtr:otherNames>Parisinos CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>UsakmkjgTXx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>300968D3-6C78-49E7-9C43-CB58D669A300</gtr:id><gtr:title>The genetics of Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Annual review of genomics and human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f444492accbb6a473246d6fe44c8a127"><gtr:id>f444492accbb6a473246d6fe44c8a127</gtr:id><gtr:otherNames>Van Limbergen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1527-8204</gtr:issn><gtr:outcomeId>BA426C44B66</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82CAB082-9A35-4505-BDD7-F84E4A6C6F9E</gtr:id><gtr:title>Use of Laboratory Markers in Addition to Symptoms for Diagnosis of Inflammatory Bowel Disease in Children: A Meta-analysis of Individual Patient Data.</gtr:title><gtr:parentPublicationTitle>JAMA pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e3435f6e16477a27b44f4af9f334347"><gtr:id>8e3435f6e16477a27b44f4af9f334347</gtr:id><gtr:otherNames>Holtman GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2168-6203</gtr:issn><gtr:outcomeId>5aaa63d8d67555.78192538</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEF290A1-7D0D-4300-BF3E-B120DBAF876F</gtr:id><gtr:title>Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia.</gtr:title><gtr:parentPublicationTitle>Archives of general psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c48199838cc2f29a1eac9e5f8f6b0422"><gtr:id>c48199838cc2f29a1eac9e5f8f6b0422</gtr:id><gtr:otherNames>Grozeva D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-990X</gtr:issn><gtr:outcomeId>KkCJE7YYw7b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13C884D2-1108-4F83-B5F6-21B2859EDCC9</gtr:id><gtr:title>Single nucleotide polymorphisms that increase expression of the guanosine triphosphatase RAC1 are associated with ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52c5be27aaf2a70d86136ab7214ebf96"><gtr:id>52c5be27aaf2a70d86136ab7214ebf96</gtr:id><gtr:otherNames>Muise AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>sytC11btZhg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9657943F-B0D2-4B9F-BDB4-D80CD3E50CDF</gtr:id><gtr:title>Serum C-reactive protein and CRP genotype in pediatric inflammatory bowel disease: influence on phenotype, natural history, and response to therapy.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>551048425e1302.54749176</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B278F56C-9EFB-4686-ABCA-B4B9E3BB4996</gtr:id><gtr:title>A case of EBV driven haemophagocytic lymphohistiocytosis complicating a teenage Crohn's disease patient on azathioprine, successfully treated with rituximab.</gtr:title><gtr:parentPublicationTitle>Journal of Crohn's &amp; colitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/492c4996893187e446a5be8199257b0c"><gtr:id>492c4996893187e446a5be8199257b0c</gtr:id><gtr:otherNames>Fitzgerald MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1873-9946</gtr:issn><gtr:outcomeId>doi_55f984984bac01e0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BEE594A-2C58-462E-9FB3-FAA44DA71CEC</gtr:id><gtr:title>NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52c5be27aaf2a70d86136ab7214ebf96"><gtr:id>52c5be27aaf2a70d86136ab7214ebf96</gtr:id><gtr:otherNames>Muise AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>K3NesMHxC1k</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF83F396-7C0B-41CD-A2BB-72FF3F9BA7E0</gtr:id><gtr:title>Letter: faecal calprotectin and lactoferrin - accurate biomarkers in post-operative Crohn's disease - authors' reply. Letter: biologic therapies are effective for prevention of post-operative Crohn's disease recurrence - authors' reply.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc5db65cb0365641c12089dcf2c6679e"><gtr:id>cc5db65cb0365641c12089dcf2c6679e</gtr:id><gtr:otherNames>Jones GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>545a3a32cf9ea9.64343215</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90690447-7AA1-41D9-BD17-ECE11B8259AE</gtr:id><gtr:title>Lack of association between cervical dysplasia and IBD: a large case-control study.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bd368253fec639b465fd164d29cb2ba"><gtr:id>2bd368253fec639b465fd164d29cb2ba</gtr:id><gtr:otherNames>Lees CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>VtsVJkzf7qn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD2F9599-AE52-4C08-84A7-240A8FC012C1</gtr:id><gtr:title>Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin D.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09cfc8db9d3df695e158267049a53fe6"><gtr:id>09cfc8db9d3df695e158267049a53fe6</gtr:id><gtr:otherNames>Flanagan PK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>58b95f2f8eb030.25205860</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DEE2ABC-A2DA-4655-8CE4-5ECA08D06869</gtr:id><gtr:title>Can Thiopurines Prevent Formation of Antibodies Against Tumor Necrosis Factor Antagonists After Failure of These Therapies?</gtr:title><gtr:parentPublicationTitle>Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28b1a25bedef401550366563cc3c49fc"><gtr:id>28b1a25bedef401550366563cc3c49fc</gtr:id><gtr:otherNames>Boyapati RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1542-3565</gtr:issn><gtr:outcomeId>58b95f2b78ce47.61996198</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B54B9A5D-E442-45AE-85BA-CE20C895F725</gtr:id><gtr:title>Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0500302ec0ed3b4bb9ae529ddf8d8f88"><gtr:id>0500302ec0ed3b4bb9ae529ddf8d8f88</gtr:id><gtr:otherNames>Kennedy NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>56d5905670cfd4.36847884</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67070890-3368-4512-BD9D-58508D99CBA2</gtr:id><gtr:title>Seven newly identified loci for autoimmune thyroid disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/944c80fb10c6590f6168fa3c3cf2c8c1"><gtr:id>944c80fb10c6590f6168fa3c3cf2c8c1</gtr:id><gtr:otherNames>Cooper JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_15892_22_22922229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A16153F1-F4FD-4449-9F25-C8B360ADF5DE</gtr:id><gtr:title>Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7df3307e11c9bb132b88045342e68068"><gtr:id>7df3307e11c9bb132b88045342e68068</gtr:id><gtr:otherNames>Ruark E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_15892_22_23242139</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFC3E17E-3284-450B-9F19-FA8334BE0CA1</gtr:id><gtr:title>The rising incidence of paediatric-onset inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>pm_16612_22_22745290</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55A50F44-ABEB-4867-AE58-0789FCDD4E09</gtr:id><gtr:title>Pooled sequencing of 531 genes in inflammatory bowel disease identifies an associated rare variant in BTNL2 and implicates other immune related genes.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/445a6cbea1ff0c3d67d561dda89695ca"><gtr:id>445a6cbea1ff0c3d67d561dda89695ca</gtr:id><gtr:otherNames>Prescott NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>56e1738b482a30.68471028</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14B90E2F-5FB0-4331-90CB-C4EE65E4E744</gtr:id><gtr:title>The diagnostic approach to monogenic very early onset inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34deb8086e8821ab36e31d6eb94c7d38"><gtr:id>34deb8086e8821ab36e31d6eb94c7d38</gtr:id><gtr:otherNames>Uhlig HH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>5464c1750f05a2.80039219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFBAC8EA-23D5-4625-B31B-C79C80B7A765</gtr:id><gtr:title>Biosimilar infliximab use in paediatric IBD.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8862a26734f3187f09d5717b2de35f6c"><gtr:id>8862a26734f3187f09d5717b2de35f6c</gtr:id><gtr:otherNames>Richmond L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>5aaa644900af57.82728334</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59802EAE-73DD-43E3-A43A-4945D313D607</gtr:id><gtr:title>Characterisation of osteoprotegerin autoantibodies in coeliac disease.</gtr:title><gtr:parentPublicationTitle>Calcified tissue international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8924067a61debc954d4516114f2908a2"><gtr:id>8924067a61debc954d4516114f2908a2</gtr:id><gtr:otherNames>Real A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0171-967X</gtr:issn><gtr:outcomeId>58b95f2f11e9b3.25352146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64295F2E-BD4E-4B5F-A5F1-AD23A151E0BD</gtr:id><gtr:title>Management of ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44825b63f5849da32252d083e4f88ab5"><gtr:id>44825b63f5849da32252d083e4f88ab5</gtr:id><gtr:otherNames>Fell JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>585d55c0cfcfb1.70806862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>682D8314-5D6C-4BA3-89AD-AB762E505BF2</gtr:id><gtr:title>Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN.</gtr:title><gtr:parentPublicationTitle>The American journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e2d0947beef3a4da746fc9d89cbb670"><gtr:id>0e2d0947beef3a4da746fc9d89cbb670</gtr:id><gtr:otherNames>Turner D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9270</gtr:issn><gtr:outcomeId>twiZ4Vue4by</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>568B11EB-97A3-4CFC-A493-CBD311EA5945</gtr:id><gtr:title>Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ba4484ccc898295a012002024ec60c3"><gtr:id>8ba4484ccc898295a012002024ec60c3</gtr:id><gtr:otherNames>de Lange KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58d1517772b7c4.20942208</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAFB2C70-3C65-4C85-B1AB-415DD09D69D5</gtr:id><gtr:title>Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a32e5e38a8b83514d902fbe4626b80ee"><gtr:id>a32e5e38a8b83514d902fbe4626b80ee</gtr:id><gtr:otherNames>Wellcome Trust Case Control Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>JAR41cJCm2Q</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AD51BD2-CD8C-4D92-AD6D-BB416BDE8BBB</gtr:id><gtr:title>The effects of anti-TNF-a treatment with adalimumab on growth in children with Crohn's disease (CD).</gtr:title><gtr:parentPublicationTitle>Journal of Crohn's &amp; colitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff310746e9ace20777a8783a2e3393dd"><gtr:id>ff310746e9ace20777a8783a2e3393dd</gtr:id><gtr:otherNames>Malik S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1873-9946</gtr:issn><gtr:outcomeId>pm_16612_22_22405171</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA30404E-19FB-4088-A527-D4EEA607D9B9</gtr:id><gtr:title>Filaggrin loss-of-function variants are associated with atopic comorbidity in pediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f444492accbb6a473246d6fe44c8a127"><gtr:id>f444492accbb6a473246d6fe44c8a127</gtr:id><gtr:otherNames>Van Limbergen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>DbBaJGFjBPD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEB3712D-FAAB-464E-B3DB-3FF03DD800B0</gtr:id><gtr:title>Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f08243406518279380370a3fd236f37"><gtr:id>4f08243406518279380370a3fd236f37</gtr:id><gtr:otherNames>Liu JZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58b98783bd4a65.18936381</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1DF6115-D2E2-4B74-8929-43F110EC7556</gtr:id><gtr:title>How to Apply for and Secure EU Funding for Collaborative IBD Research Projects.</gtr:title><gtr:parentPublicationTitle>Journal of Crohn's &amp; colitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5da24c4aa9fd3d3f04a822291d0cbde0"><gtr:id>5da24c4aa9fd3d3f04a822291d0cbde0</gtr:id><gtr:otherNames>Satsangi J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-9946</gtr:issn><gtr:outcomeId>56d590d59db902.37993287</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3902A676-D74C-41A6-9D4D-B478F8281FC6</gtr:id><gtr:title>Measurement methods and accuracy in copy number variation: failure to replicate associations of beta-defensin copy number with Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f464f9e14d797f32cb291cb1c8e1802b"><gtr:id>f464f9e14d797f32cb291cb1c8e1802b</gtr:id><gtr:otherNames>Aldhous MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>eCiPTvpufSX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8B8C1CC-C748-4004-9AA4-A0EF3F2B5459</gtr:id><gtr:title>Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b004e39d62a9fcb4cc88a22083af34fa"><gtr:id>b004e39d62a9fcb4cc88a22083af34fa</gtr:id><gtr:otherNames>International Multiple Sclerosis Genetics Consortium (IMSGC)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>56e17613414cd8.36193009</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F8231D0-A9B8-4128-B1BB-2D15DBCF8689</gtr:id><gtr:title>Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a94bd817e0697ab1ede1ac552afec188"><gtr:id>a94bd817e0697ab1ede1ac552afec188</gtr:id><gtr:otherNames>Wain LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn><gtr:outcomeId>58b95f2ec62925.28949032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DECAA2F6-4B9B-40A6-A041-0A4EFE970E5D</gtr:id><gtr:title>Haplotype-tagging analysis of common variants of the IL23R gene demonstrates gene-wide extent of association with IBD.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f444492accbb6a473246d6fe44c8a127"><gtr:id>f444492accbb6a473246d6fe44c8a127</gtr:id><gtr:otherNames>Van Limbergen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>5464c033e785a6.44861697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B28BD4C-2300-450F-BCFA-870F47EC093C</gtr:id><gtr:title>Changes to serum sample tube and processing methodology does not cause Intra-Individual [corrected] variation in automated whole serum N-glycan profiling in health and disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be7f3c9c818fb8f7c8a3e8507c421eed"><gtr:id>be7f3c9c818fb8f7c8a3e8507c421eed</gtr:id><gtr:otherNames>Ventham NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58b95f2fdc86e1.37722175</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE1242D8-6B65-4841-B768-7082C98A812D</gtr:id><gtr:title>The fungal microbiota of de-novo paediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Microbes and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/722af0128dd76befcd7920473a7ec52e"><gtr:id>722af0128dd76befcd7920473a7ec52e</gtr:id><gtr:otherNames>Mukhopadhya I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1286-4579</gtr:issn><gtr:outcomeId>doi_55f984984bb5b1d1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A09EDD40-996B-480A-9111-BDD250395637</gtr:id><gtr:title>Paneth cell marker CD24 in NOD2 knockout organoids and in inflammatory bowel disease (IBD).</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f444492accbb6a473246d6fe44c8a127"><gtr:id>f444492accbb6a473246d6fe44c8a127</gtr:id><gtr:otherNames>Van Limbergen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>doi_16612_013_305077</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3F1228D-3E70-4053-B40A-EC77A39435B7</gtr:id><gtr:title>The rising incidence of celiac disease in Scotland.</gtr:title><gtr:parentPublicationTitle>Pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56c5ef6be6dae8d6e76504fc87e6dce2"><gtr:id>56c5ef6be6dae8d6e76504fc87e6dce2</gtr:id><gtr:otherNames>White LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0031-4005</gtr:issn><gtr:outcomeId>doi_16612__2013_0932</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>331EC245-7424-4EBB-B0C4-D7205C4EEEFB</gtr:id><gtr:title>Two-stage genome-wide methylation profiling in childhood-onset Crohn's Disease implicates epigenetic alterations at the VMP1/MIR21 and HLA loci.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/046e1f58ff3098759bf68f5a319c054a"><gtr:id>046e1f58ff3098759bf68f5a319c054a</gtr:id><gtr:otherNames>Adams AT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>5464c033c1d473.40955812</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C20992F-917A-4AFE-88F3-778A89D02D7F</gtr:id><gtr:title>pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19956025010c7cc0e142741034f526e9"><gtr:id>19956025010c7cc0e142741034f526e9</gtr:id><gtr:otherNames>Birimberg-Schwartz L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>585d67728b7d37.78571609</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>909D499A-D2B7-4FB1-8E1A-D365A73A8A84</gtr:id><gtr:title>Rising incidence of pediatric inflammatory bowel disease in Scotland.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>cr219MEoAnp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5115162-1D89-44DE-8A20-CD32087DE74A</gtr:id><gtr:title>Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f08243406518279380370a3fd236f37"><gtr:id>4f08243406518279380370a3fd236f37</gtr:id><gtr:otherNames>Liu JZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>56e1742a6c1902.00469143</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86B2C344-545B-419C-9DE8-0E12D791646A</gtr:id><gtr:title>Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be7f3c9c818fb8f7c8a3e8507c421eed"><gtr:id>be7f3c9c818fb8f7c8a3e8507c421eed</gtr:id><gtr:otherNames>Ventham NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58d15177e2a2c0.05685837</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9B8F9D6-2818-4CBF-8895-958889F8AB8F</gtr:id><gtr:title>Psychosocial functioning and health-related quality of life in paediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Journal of pediatric gastroenterology and nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/886606afd4f9c4c3637aefb0a28e1750"><gtr:id>886606afd4f9c4c3637aefb0a28e1750</gtr:id><gtr:otherNames>Ross SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0277-2116</gtr:issn><gtr:outcomeId>pm_16612_22_21822149</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B536E70-5F56-4D45-905B-EED2A9670319</gtr:id><gtr:title>Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5b403a7f6ad6f739fef6c9fb0b8f1fd"><gtr:id>d5b403a7f6ad6f739fef6c9fb0b8f1fd</gtr:id><gtr:otherNames>Luo Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58d1517740e4f0.19358405</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8451D907-9073-404C-B482-1F42FFF4650E</gtr:id><gtr:title>Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be7f3c9c818fb8f7c8a3e8507c421eed"><gtr:id>be7f3c9c818fb8f7c8a3e8507c421eed</gtr:id><gtr:otherNames>Ventham NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>pm_15892_22_23751777</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D8B8168-45B3-41C5-8BC0-EC7C307118E2</gtr:id><gtr:title>Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35327529ca4f1df9cff05f5b7d814159"><gtr:id>35327529ca4f1df9cff05f5b7d814159</gtr:id><gtr:otherNames>Armstrong L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>doi_55f984984bca272e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAF78390-3FAD-4D04-9B21-1EDF81749337</gtr:id><gtr:title>Systematic meta-analyses and field synopsis of genetic and epigenetic studies in paediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93f8556619f3487d06c35513ec7d86fb"><gtr:id>93f8556619f3487d06c35513ec7d86fb</gtr:id><gtr:otherNames>Li X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58b95f2bb9b2e7.44500489</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AF7CEF5-485B-4DA9-9DBE-7F844B270D59</gtr:id><gtr:title>A case of posterior reversible encephalopathy syndrome in a child with Crohn's disease treated with Infliximab.</gtr:title><gtr:parentPublicationTitle>Journal of Crohn's &amp; colitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/703355cd429860adb18008d70338c8e9"><gtr:id>703355cd429860adb18008d70338c8e9</gtr:id><gtr:otherNames>Haddock R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1873-9946</gtr:issn><gtr:outcomeId>doi_55f984984ba299f2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3CEDE17-1741-410B-A81E-4561D7389093</gtr:id><gtr:title>The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0500302ec0ed3b4bb9ae529ddf8d8f88"><gtr:id>0500302ec0ed3b4bb9ae529ddf8d8f88</gtr:id><gtr:otherNames>Kennedy NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5464c0e91ad254.56501399</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C6CB6A8-A200-4576-91BB-20B38EBD1126</gtr:id><gtr:title>Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0500302ec0ed3b4bb9ae529ddf8d8f88"><gtr:id>0500302ec0ed3b4bb9ae529ddf8d8f88</gtr:id><gtr:otherNames>Kennedy NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>545a388dc1a454.19385979</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A611622-E035-4541-B0DD-B94781D5D2F5</gtr:id><gtr:title>Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50e6243a98509e54910c6932cb74b8db"><gtr:id>50e6243a98509e54910c6932cb74b8db</gtr:id><gtr:otherNames>Lee JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>doi_16612_013_08_034</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AAC86FF-F7E1-4312-9369-D53DB30BBCC0</gtr:id><gtr:title>A Method to Exploit the Structure of Genetic Ancestry Space to Enhance Case-Control Studies.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/115678a5f93d1df09c752d1cca5b1c48"><gtr:id>115678a5f93d1df09c752d1cca5b1c48</gtr:id><gtr:otherNames>Bodea CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>58b95f2d9537c6.45708707</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB138B13-6454-4890-AEA5-7E22B7F40CD2</gtr:id><gtr:title>Anti-TNF therapy for paediatric IBD: the Scottish national experience.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c5840b49afd918f3f3f911a699aa139"><gtr:id>1c5840b49afd918f3f3f911a699aa139</gtr:id><gtr:otherNames>Cameron FL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>doi_55f984984bd46761</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1031578-CB72-4205-A1C6-B7ACCF5BF904</gtr:id><gtr:title>Growth in children receiving contemporary disease specific therapy for Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff310746e9ace20777a8783a2e3393dd"><gtr:id>ff310746e9ace20777a8783a2e3393dd</gtr:id><gtr:otherNames>Malik S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>pm_16612_22_22685044</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F0D9EEB-D97A-435A-9474-64104A2402CF</gtr:id><gtr:title>Cigarette smoke extract (CSE) delays NOD2 expression and affects NOD2/RIPK2 interactions in intestinal epithelial cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f464f9e14d797f32cb291cb1c8e1802b"><gtr:id>f464f9e14d797f32cb291cb1c8e1802b</gtr:id><gtr:otherNames>Aldhous MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545a4698ae4360.09974213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A01E6232-145A-446A-A54B-DD93CADC66DC</gtr:id><gtr:title>Exploring the hidden heritability of inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5da24c4aa9fd3d3f04a822291d0cbde0"><gtr:id>5da24c4aa9fd3d3f04a822291d0cbde0</gtr:id><gtr:otherNames>Satsangi J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>CGaDmPjTtEb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69165909-AF21-410F-82E0-36F23D076073</gtr:id><gtr:title>Extensive Modulation of the Fecal Metagenome in Children With Crohn's Disease During Exclusive Enteral Nutrition.</gtr:title><gtr:parentPublicationTitle>The American journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17620d321d3b329acfee3c0bd6e3632c"><gtr:id>17620d321d3b329acfee3c0bd6e3632c</gtr:id><gtr:otherNames>Quince C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9270</gtr:issn><gtr:outcomeId>585d561ba164b0.09534919</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AC41749-D9FD-427C-8C73-4FDBA19B1D5C</gtr:id><gtr:title>Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28d5e44cfd0fb461260062e89bab9868"><gtr:id>28d5e44cfd0fb461260062e89bab9868</gtr:id><gtr:otherNames>Hunt KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_16612_22_22200769</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4F2E0A8-43D6-4435-9952-4DB62A6470F6</gtr:id><gtr:title>Nationwide linkage analysis in Scotland to assess mortality following hospital admission for Crohn's disease: 1998-2000.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0500302ec0ed3b4bb9ae529ddf8d8f88"><gtr:id>0500302ec0ed3b4bb9ae529ddf8d8f88</gtr:id><gtr:otherNames>Kennedy NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>pm_15892_22_22070187</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED00DBE5-87A5-4051-94F0-97309A9D041C</gtr:id><gtr:title>Biomarkers in Search of Precision Medicine in IBD.</gtr:title><gtr:parentPublicationTitle>The American journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28b1a25bedef401550366563cc3c49fc"><gtr:id>28b1a25bedef401550366563cc3c49fc</gtr:id><gtr:otherNames>Boyapati RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9270</gtr:issn><gtr:outcomeId>58b95f2c026cf6.54458369</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF7BF020-68FF-46A6-AE68-824A293A9D33</gtr:id><gtr:title>Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>oBm23VbrLMC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F412198B-99E4-4AAD-BB11-41ED23E838ED</gtr:id><gtr:title>Magnetic resonance follow-through imaging for evaluation of disease activity in ileal Crohn's disease: an observational, retrospective cohort study.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bffe2c88e0743de298720c2901b77790"><gtr:id>bffe2c88e0743de298720c2901b77790</gtr:id><gtr:otherNames>Parisinos CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>E7bBfWuBCLk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75962898-12FA-41A6-AE1F-09719C39B369</gtr:id><gtr:title>Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bd098697bd70f44f21e158259d0b6f4"><gtr:id>1bd098697bd70f44f21e158259d0b6f4</gtr:id><gtr:otherNames>Rivas MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_16612_22_21983784</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD50F9F5-D581-4561-8C51-8EF19E1B70F4</gtr:id><gtr:title>Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>The Journal of pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9eeda35358bcc4dfe61af28779ec9474"><gtr:id>9eeda35358bcc4dfe61af28779ec9474</gtr:id><gtr:otherNames>Barclay AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3476</gtr:issn><gtr:outcomeId>CQ9fRzksXgm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41EB931B-BB09-42F6-9D53-781AB7ABDBD7</gtr:id><gtr:title>Crohn's disease.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7cfe472cce65a6e4c1409d62261cbc1"><gtr:id>a7cfe472cce65a6e4c1409d62261cbc1</gtr:id><gtr:otherNames>Kalla R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>551048e730be34.81064895</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>516534BC-A6F1-4E0F-9B8F-02CAC14B7CD5</gtr:id><gtr:title>Treatment Options and Outcomes of Pediatric IBDU Compared with Other IBD Subtypes: A Retrospective Multicenter Study from the IBD Porto Group of ESPGHAN.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b62e0c846f35d4fdfa1e6d3c1bc9e68"><gtr:id>2b62e0c846f35d4fdfa1e6d3c1bc9e68</gtr:id><gtr:otherNames>Aloi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>585d676f466640.81831097</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CB269ED-3877-4DF6-8771-66D316B860A1</gtr:id><gtr:title>Sight-threatening keratopathy complicating anti-TNF therapy in Crohn's disease: a case report.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/254011e3badfd4e4a467be550b37a45c"><gtr:id>254011e3badfd4e4a467be550b37a45c</gtr:id><gtr:otherNames>Fasci-Spurio F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>545a3bc397d523.29043370</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF6A3745-9806-4A5E-ACFA-7836986042C2</gtr:id><gtr:title>Genetic sharing and heritability of paediatric age of onset autoimmune diseases.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1605ad728ecb6d5cabf79b7add99fc60"><gtr:id>1605ad728ecb6d5cabf79b7add99fc60</gtr:id><gtr:otherNames>Li YR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56e171dfbe5e49.17562861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D77EBC7-7CF9-47EB-B3D6-9644B3FCA126</gtr:id><gtr:title>Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases.</gtr:title><gtr:parentPublicationTitle>The American journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7cfe472cce65a6e4c1409d62261cbc1"><gtr:id>a7cfe472cce65a6e4c1409d62261cbc1</gtr:id><gtr:otherNames>Kalla R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9270</gtr:issn><gtr:outcomeId>58d15178498e60.13196822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5516C66E-64CF-4433-96F6-CBC446CF7DF3</gtr:id><gtr:title>Disease Status and Pubertal Stage Predict Improved Growth in Antitumor Necrosis Factor Therapy for Pediatric Inflammatory Bowel Disease.</gtr:title><gtr:parentPublicationTitle>Journal of pediatric gastroenterology and nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c5840b49afd918f3f3f911a699aa139"><gtr:id>1c5840b49afd918f3f3f911a699aa139</gtr:id><gtr:otherNames>Cameron FL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0277-2116</gtr:issn><gtr:outcomeId>58d151781bb123.06803733</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1ADD95E-6B69-4776-8DF1-EE2C56B09380</gtr:id><gtr:title>Editorial: Early corticosteroids in ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0500302ec0ed3b4bb9ae529ddf8d8f88"><gtr:id>0500302ec0ed3b4bb9ae529ddf8d8f88</gtr:id><gtr:otherNames>Kennedy NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>545a39ef2cf781.94320924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>726F998F-0B3E-4E4F-82AC-0EBF6755D9EF</gtr:id><gtr:title>Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16-50 years.</gtr:title><gtr:parentPublicationTitle>Journal of Crohn's &amp; colitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0500302ec0ed3b4bb9ae529ddf8d8f88"><gtr:id>0500302ec0ed3b4bb9ae529ddf8d8f88</gtr:id><gtr:otherNames>Kennedy NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1873-9946</gtr:issn><gtr:outcomeId>545a39ab9c78a4.95440171</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FF9BD0A-737E-4BE1-B3EB-FD9AF7C9595E</gtr:id><gtr:title>Nationwide linkage analysis in Scotland-Has mortality following hospital admission for Crohn's disease changed in the early 21st century?</gtr:title><gtr:parentPublicationTitle>Journal of Crohn's &amp; colitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be7f3c9c818fb8f7c8a3e8507c421eed"><gtr:id>be7f3c9c818fb8f7c8a3e8507c421eed</gtr:id><gtr:otherNames>Ventham NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1873-9946</gtr:issn><gtr:outcomeId>545a3912d32900.39914675</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EF65151-9D4E-422A-A81D-10BDC79446E8</gtr:id><gtr:title>High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/906af871a1f703f6246584282b1313b8"><gtr:id>906af871a1f703f6246584282b1313b8</gtr:id><gtr:otherNames>Eyre S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_15892_22_23143596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4AF48FF-1185-45FC-AAC3-CBD4A3BD859C</gtr:id><gtr:title>A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0500302ec0ed3b4bb9ae529ddf8d8f88"><gtr:id>0500302ec0ed3b4bb9ae529ddf8d8f88</gtr:id><gtr:otherNames>Kennedy NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>pm_15892_22_24117596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>339A4786-CEA7-4FA8-9475-34FB5D0A3EDD</gtr:id><gtr:title>Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67c4802bef8cffec7e1326194d07eaa1"><gtr:id>67c4802bef8cffec7e1326194d07eaa1</gtr:id><gtr:otherNames>Jostins L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_16612_22_23128233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8357DDE-ACDA-4FD4-B99E-41CEE42E0F56</gtr:id><gtr:title>Guidelines for the management of inflammatory bowel disease in adults.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5872a5fbb017c81d000ff8540547d87a"><gtr:id>5872a5fbb017c81d000ff8540547d87a</gtr:id><gtr:otherNames>Mowat C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>KtfRw17SVWN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEEBB341-60CA-4C19-9A8D-F971E07B37FF</gtr:id><gtr:title>Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee2f00367823c286d1309d18b6f74ea2"><gtr:id>ee2f00367823c286d1309d18b6f74ea2</gtr:id><gtr:otherNames>Trbojevic Akmacic I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>56d59285c8e304.79794692</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0FE599B-4B83-45E2-9881-7BB967498DAB</gtr:id><gtr:title>Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28b1a25bedef401550366563cc3c49fc"><gtr:id>28b1a25bedef401550366563cc3c49fc</gtr:id><gtr:otherNames>Boyapati RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>58c132fae3bd01.51152525</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F3DE32D-5028-4DD7-AC8A-E51E9315CF01</gtr:id><gtr:title>Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a31994e93582d0033292b37419bb3c5"><gtr:id>5a31994e93582d0033292b37419bb3c5</gtr:id><gtr:otherNames>Hawkey CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>56d591072b9aa5.82876438</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4F23901-3FC3-4789-8AB7-DFEA33F47D65</gtr:id><gtr:title>The changing epidemiology of paediatric inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Alimentary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0269-2813</gtr:issn><gtr:outcomeId>pm_16612_22_21569065</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F629E16-FB82-4C6D-AA0D-4212B7768C2E</gtr:id><gtr:title>The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>The American journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9270</gtr:issn><gtr:outcomeId>doi_16612_g_2013_131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DDB0C44-0769-403A-8D43-7E0E219014D1</gtr:id><gtr:title>Advances in IBD genetics.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f444492accbb6a473246d6fe44c8a127"><gtr:id>f444492accbb6a473246d6fe44c8a127</gtr:id><gtr:otherNames>Van Limbergen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-5045</gtr:issn><gtr:outcomeId>545a3b484ade24.77967959</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBF46308-2F09-4518-87D5-9AD3BE97910F</gtr:id><gtr:title>Variation in ICOSLG influences Crohn's disease susceptibility.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/205afd942c97b437dd3f520fe9bdad74"><gtr:id>205afd942c97b437dd3f520fe9bdad74</gtr:id><gtr:otherNames>Henderson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>qTZn9NE8Dfv</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800675</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>